BioHarvest Sciences FY2025 U.S. revenue rises to more than $30 million; active users climb to more than 85,000
Reuters
Mar 26
BioHarvest Sciences FY2025 U.S. revenue rises to more than $30 million; active users climb to more than 85,000
BioHarvest said its VINIA brand ranked No. 1 in the US resveratrol polyphenol nutraceutical category based on 2025 annual sales revenue.
The company reported more than USD 30 million in US revenue for 2025 and approximately USD 85 million in global cumulative revenue to date.
BioHarvest said VINIA.com accounted for approximately 80% of VINIA US revenue.
The company reported more than 85,000 active VINIA users across the US and Israel.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief on March 26, 2026, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.